- Home
- GRC vs NKTR Comparison
GRC vs NKTR Comparison
Compare GRC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRC
- NKTR
- Stock Information
- Founded
- GRC 1933
- NKTR 1990
- Country
- GRC United States
- NKTR United States
- Employees
- GRC N/A
- NKTR N/A
- Industry
- GRC Fluid Controls
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- GRC Industrials
- NKTR Health Care
- Exchange
- GRC Nasdaq
- NKTR Nasdaq
- Market Cap
- GRC 1.2B
- NKTR 1.1B
- IPO Year
- GRC N/A
- NKTR 1994
- Fundamental
- Price
- GRC $44.99
- NKTR $57.07
- Analyst Decision
- GRC
- NKTR Strong Buy
- Analyst Count
- GRC 0
- NKTR 5
- Target Price
- GRC N/A
- NKTR $89.00
- AVG Volume (30 Days)
- GRC 76.7K
- NKTR 811.8K
- Earning Date
- GRC 10-24-2025
- NKTR 11-06-2025
- Dividend Yield
- GRC 1.69%
- NKTR N/A
- EPS Growth
- GRC 31.51
- NKTR N/A
- EPS
- GRC 1.91
- NKTR N/A
- Revenue
- GRC $678,522,000.00
- NKTR $62,600,000.00
- Revenue This Year
- GRC $4.94
- NKTR N/A
- Revenue Next Year
- GRC $4.02
- NKTR N/A
- P/E Ratio
- GRC $23.55
- NKTR N/A
- Revenue Growth
- GRC 3.19
- NKTR N/A
- 52 Week Low
- GRC $30.87
- NKTR $6.48
- 52 Week High
- GRC $49.25
- NKTR $66.92
- Technical
- Relative Strength Index (RSI)
- GRC 47.87
- NKTR 49.56
- Support Level
- GRC $44.00
- NKTR $54.59
- Resistance Level
- GRC $46.68
- NKTR $59.38
- Average True Range (ATR)
- GRC 1.15
- NKTR 3.78
- MACD
- GRC -0.09
- NKTR -0.76
- Stochastic Oscillator
- GRC 38.43
- NKTR 31.45
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.